The host inflammatory response prior to death in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection (Q57913826)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

The host inflammatory response prior to death in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

0 references

1 reference

Pseudomonas aeruginosa

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

S M Cordon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

D Parker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

F M Delamere

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

D J Shale

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 November 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

603-607

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

Cystic fibrosis. 2. Lung injury in cystic fibrosis

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Granulocyte elastase-alpha 1-antiproteinase complex in cystic fibrosis: sensitive plasma assay for monitoring pulmonary infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Inflammatory markers in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Pseudomonas aeruginosa antibodies in blood spots from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Serum C-reactive protein in assessment of pulmonary exacerbations and antimicrobial therapy in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Diagnostic criteria for adult respiratory distress syndrome: time for reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Tumor necrosis factor and disease severity in children with falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

Tumors secreting human TNF/cachectin induce cachexia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980263-X

7 January 2021

10.1016/S0954-6111(05)80263-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8290744%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference